Vimarsana
Biggest News Aggregation in the World

Page 23 - Major Project News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Major Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Major Project Today - Breaking & Trending Today

Ascentage Pharma and Innovent Biologics Announce Approval for China's First Third-Generation BCR-ABL TKI Olverembatinib, Marking a Clinical Breakthrough in the Treatment of Chronic Myeloid Leukemia - Vimarsana News

Ascentage Pharma and Innovent Biologics Announce Approval for China's First Third-Generation BCR-ABL TKI Olverembatinib, Marking a Clinical Breakthrough in the Treatment of Chronic Myeloid Leukemia

Published: December 1, 2021

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Source: prnewswire.com
Related Topics:
United StatesHong KongQian JiangWestern AustraliaInnovent BiologicsAscentage PharmaEli LillyPrnewswire Ascentage PharmaXiaojun HuangDajun YangAdimab IncyteYifan ZhaiMichael YuHealthquest PharmaXue Za ZhiMajor NationalGuangzhou Healthquest Pharma Co Ltd IncInstitute Of HematologyMd Anderson Cancer CenterAmerican Society Of HematologyNational Major New Drug DiscoveryChina National Medical Products AdministrationEuropean UnionDana Farber Cancer InstituteHematology Department At Peking University People Hospital
Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer - Vimarsana News

Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer

Published: November 29, 2021

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Source: prnewswire.com
Related Topics:
Hong KongWestern AustraliaDajun YangAscentage PharmaPrnewswire Ascentage PharmaFosun PharmaMajor NationalChina Europe International Business SchoolExpert Committee For South ChinaDepartment Of Food Science EngineeringMd Anderson Cancer CenterInstitute Of Management AccountantsShanghai Jiao Tong UniversityErnst YoungDana Farber Cancer InstituteAssociation Of Chartered Certified AccountantsYiqing ChenChief Financial OfficerChief Executive OfficerGeneral ManagerInvestor RelationsCapital DeploymentDeputy General ManagerInitial Public OfferingInvestment Banking
Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer - Vimarsana News

Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer

Published: November 29, 2021

Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com
Related Topics:
Hong KongWestern AustraliaDajun YangAscentage PharmaPrnewswire Ascentage PharmaFosun PharmaMajor NationalChina Europe International Business SchoolExpert Committee For South ChinaDepartment Of Food Science EngineeringMd Anderson Cancer CenterInstitute Of Management AccountantsShanghai Jiao Tong UniversityErnst YoungDana Farber Cancer InstituteAssociation Of Chartered Certified AccountantsYiqing ChenChief Financial OfficerChief Executive OfficerGeneral ManagerInvestor RelationsCapital DeploymentDeputy General ManagerInitial Public OfferingInvestment Banking
Ascentage Pharma's Olverembatinib Granted Orphan Designation by the European Commission for the Treatment of Chronic Myeloid Leukemia - Vimarsana News

Ascentage Pharma's Olverembatinib Granted Orphan Designation by the European Commission for the Treatment of Chronic Myeloid Leukemia

Published: November 22, 2021

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Source: prnewswire.com
Related Topics:
United StatesHong KongWestern AustraliaAscentage PharmaYifan ZhaiPrnewswire Ascentage PharmaMajor NationalEuropean CommissionDrug AdministrationMd Anderson Cancer CenterAmerican Society Of HematologyCommittee For Orphan Medicinal ProductsEuropean UnionEuropean Medicines AgencyNational Medical Products AdministrationDana Farber Cancer InstituteOrphan DesignationOrphan DesignationsOrphan Medicinal ProductsNew Drug ApplicationBreakthrough Therapy DesignationDrug EvaluationOrphan Drug DesignationFast Track DesignationAmerican Society
ASH 2021 | Ascentage Pharma to Release Latest Data from Two Studies of Its Bcl-2-Selective Inhibitor Lisaftoclax (APG-2575), Including a Chinese Study Demonstrating Complete Response - Vimarsana News

ASH 2021 | Ascentage Pharma to Release Latest Data from Two Studies of Its Bcl-2-Selective Inhibitor Lisaftoclax (APG-2575), Including a Chinese Study Demonstrating Complete Response

Published: November 5, 2021

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Source: prnewswire.com
Related Topics:
United StatesHong KongAscentage PharmaYifan ZhaiAmerican Society Of HematologyMajor NationalEuropean UnionMd Anderson Cancer CenterDana Farber Cancer InstituteAmerican SocietyEfficacy ResultsNovel Third GenerationKinase InhibitorResistant Chronic Myeloid LeukemiaPivotal PhaseTyrosine Kinase InhibitorAccelerated Phase Chronic Myeloid LeukemiaBridging StudyOrally Administered OlverembatinibRefractory Chronic Myeloid LeukemiaCertain RelapsedHematologic MalignanciesSingle AgentRefractory Chronic LymphocyticSmall Lymphocytic Lymphoma